Viewing Study NCT01137812


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-02-05 @ 6:37 PM
Study NCT ID: NCT01137812
Status: COMPLETED
Last Update Posted: 2015-01-15
First Post: 2010-06-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Canagliflozin View
None Sitagliptin (Januvia) View
None Metformin View
None Sulphonylurea View
None Hemoglobin A1c View
None Type 2 diabetes mellitus View